Navigation Links
Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
Date:9/2/2009

BEIJING, Sept. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.

The agreement follows meetings between Sinovac and the Korean Food and Drug Administration (KFDA) and the Korean Center for Disease Control (KCDC) where Sinovac presented the scientific data of Sinovac's H1N1 vaccine. The deal gives Boryung exclusive rights to represent Sinovac in discussions with the KFDA and KCDC in the development of business opportunities in South Korea surrounding Sinovac's H1N1 vaccine. The price, volume, delivery schedule and other specific details about how Sinovac's H1N1 vaccine might be marketed and supplied to the government of South Korea have not been determined.

Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, "We chose Boryung as our potential partner in South Korea because of their well-respected position in that country and familiarity with the regulatory bodies there. As part of our commitment to developing high quality vaccines to fight the spread of disease worldwide, we are pleased to explore the possibility of marketing our first in class H1N1 vaccine in South Korea."

On August 30 and 31, 2009, the State Food and Drug Administration (SFDA) organized and held an experts' evaluation conference focused on A/H1N1 vaccines to evaluate Sinovac's H1N1 vaccine, which has recently completed a clinical trial. Top-line results from the trial demonstrated Sinovac's H1N1 vaccine to have a good safety profile and immunogenicity factor
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. Sinovac Reports Unaudited First Quarter 2009 Financial Results
5. Sinovac Schedules 2008 Annual General Meeting
6. Sinovac Reports Unaudited Second Quarter 2009 Financial Results
7. Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
8. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... SAINT PAUL, Minn. , Feb. 9 ... death, chronic obstructive pulmonary disease (COPD), is now ... Environmental Public Health Tracking Program. The program focuses ... Minnesota that can be triggered or made ... or outdoor air pollution — asthma, heart attacks ...
(Date:2/9/2010)... for the Heart with ... , Feb. 9 Show your ... gift for the heart with the new ... Recipes Made with Canola Oil" by the American Diabetes ... these recipes for love or give the cookbook as ...
(Date:2/9/2010)... In conjunction with the 2010 Super Bowl, on Feb. ... first-annual Gridiron Greats Night of Champions, a charitable event for ... and Jamie Foxx . Supported by more than ... non-profit organization that provides financial assistance and social services to ... Greats recognized LSI at the event as Medical Partner of ...
(Date:2/9/2010)... (Boston)- Researchers from Boston University,s Slone Epidemiology Center ... status and risk for type 2 diabetes in ... the online American Journal of Epidemiology , ... relationship between neighborhood socioeconomic status and incidence of ... cohort of African-American women. , Type 2 diabetes ...
(Date:2/9/2010)... at the Ireland Cancer Center of University Hospitals (UH) ... lead to a new standard of care for patients ... the February issue of Clinical Cancer Research, ... medicine, Triapine, was well tolerated in combination with standard-of-care ... cancer. This regimen provided both significant reduction in cancer ...
Breaking Medicine News(10 mins):Health News:Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007 2Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 2Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 3Health News:Laser Spine Institute Honored at the Gridiron Greats Night of Champions 2Health News:Neighborhood socioeconomic status and diabetes 2
... Too many obstetricians and hospitals use potentially harmful ... N.Y., Oct. 8 According to Consumer,Reports, many ... result in poor results for newborns and their ... maternity care by taking a quiz,available at CR,s ...
... The Lewin Group released,an independent comparative analysis of ... at the National Press Club in Washington, D.C. The,report ... http://www.lewin.com ., The firm is nationally known ... reform proposals on coverage and costs for the federal,government, ...
... China, Oct. 8 Sinobiomed Inc.,("Sinobiomed", or "the ... that its Board of Directors voted on October ... Company,s Chief Financial Officer under a,Corporate Consulting Services ... In addition, Mr. Choong has been appointed to ...
... LOUIS, Oct. 8 Mass casualty incidents --,such ... calamities,like earthquakes or hurricanes -- raise the life-and-death ... provide treatment for all who,need it. One of ... ventilators for,people requiring respiratory support., Disaster specialists ...
... BUFFALO, N.Y. Cremation, "air burial," grave cairns, funeral ... practices sacred to one culture are often considered "odd" ... were fascinated with the historian Herodotus, description of the ... grill and devouring them in a communal barbeque, something ...
... The National,Community Pharmacists Association (NCPA) is endorsing Sen. ... re-election to the,U.S. Senate. Bruce Roberts, RPh, executive ... statement:, "Senator Norm Coleman is a powerful ... patients they serve. That is why the,National Community ...
Other Medicine News:Health News:CONSUMER REPORTS: Back to Basics For Safer Childbirth 2Health News:CONSUMER REPORTS: Back to Basics For Safer Childbirth 3Health News:CONSUMER REPORTS: Back to Basics For Safer Childbirth 4Health News:CONSUMER REPORTS: Back to Basics For Safer Childbirth 5Health News:CONSUMER REPORTS: Back to Basics For Safer Childbirth 6Health News:The Lewin Group Presents 'McCain and Obama Health Policies: Cost and Coverage Compared' Analysis 2Health News:The Lewin Group Presents 'McCain and Obama Health Policies: Cost and Coverage Compared' Analysis 3Health News:The Lewin Group Presents 'McCain and Obama Health Policies: Cost and Coverage Compared' Analysis 4Health News:Sinobiomed Directors Confirm Hiring of New Chief Financial Officer 2Health News:Missouri Firm's New Ventilator Design Addresses Serious Homeland Security Issue 2Health News:Missouri Firm's New Ventilator Design Addresses Serious Homeland Security Issue 3Health News:Deathways open doors to unexpected cultural practices 2
(Date:2/9/2010)... Feb. 9 Delcath ... medical technology company testing its proprietary treatment system ... announced today the signing of its first research, ... Hepatic Perfusion (PHP) System  (the Delcath PHP System™). ... exclusive right to market and sell the Delcath ...
(Date:2/9/2010)... , Feb. 9 Palatin ... announced the completion of first cohort dosing in ... experimental treatment for sexual dysfunction.  The primary endpoint ... blood pressure effects of subcutaneous bremelanotide in men ... will also evaluate consistency of plasma exposure of ...
(Date:2/8/2010)... Calif. , Feb. 8 PreXion, ... quality 3D Cone Beam Imaging systems for dentistry, today ... as Director of Marketing. ,, PreXion President/COO ... Keith on our senior management team and I look ... extensive sales and marketing leadership, experience and success in ...
Breaking Medicine Technology:Delcath Signs First Partner Agreement in Asia 2Delcath Signs First Partner Agreement in Asia 3Delcath Signs First Partner Agreement in Asia 4Delcath Signs First Partner Agreement in Asia 5Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4PreXion, Inc. Announces Appointment of Director of Marketing 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 1NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 2NxStage Extends Supply Agreement with B Braun Medical Inc to Include Streamline 28R 29 Technology 47454 3FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 1FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 2FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 3FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 4FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 5FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 6FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 7
... - Research Collaboration to ... Jubilant Organosys Ltd, headquartered in ... Biosys Ltd, has signed a research,collaboration agreement with, ... the international pharmaceutical company,s pre-clinical,pipeline. Under the shared ...
... concludes that new cosmeceutical improves skin barrier function, erythema ... Senetek PLC (OTC Bulletin Board: SNKTY), ... technologies that target the science of healthy aging, today ... Lotion for Improving the Signs and Symptoms of Rosacea," ...
Other Medicine Technology:Jubilant Enters Research Collaboration With AstraZeneca 2Jubilant Enters Research Collaboration With AstraZeneca 3Jubilant Enters Research Collaboration With AstraZeneca 4Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2
... many years experience in the field of Urodynamics, ... Urodynamics Chair. Our new chair is manufactured from ... of Urodynamic studies can be improved considerably if ... the test, and this aspect was given a ...
The Triage Drugs of Abuse Panel is the leading rapid drug screen used by U.S. hospitals. The Triage Drugs of Abuse Panel is a small, handheld urine test that provides qualitative results for up to n...
... The Advanced Model 3900 Multi-Sample ... for laboratories processing moderate to high ... industry-preferred method of freezing-point technology for ... combined with high, continuous throughput, the ...
... Osmometer provides extremely accurate osmolality measurements ... These results are obtained by using ... total concentration. Only the model 2020 ... sample handling, and flexible reporting options ...
Medicine Products: